In contrast, the HMP1G NPs group showed abundant CD8+ T cell infiltration in the field of view with minimal levels of IDO1 and KYN, suggesting a significant improvement in the metabolic and immunosuppressive states within the tumor microenvironment following HMP1G NPs treatment. The gene discussed is CD8A; the disease is neoplasm.